BridgeMD
New treatment option for Hypnosis, Chronic Pain Management
Official title Self-hypnosis Training for Chronic Pain Management
ClinicalTrials.gov ID: NCT06279650
What this study is testing
- What it's testing
- Title: Self-hypnosis training in chronic pain management: A pilot study Our primary objective concerns the effect of hypnosis intervention on change in 24h pain between T0 (pre-intervention) and T4 (3-month follow-up). The secondary objectives concern the effects of the intervention on (i) change in 24h pain between T0 and T5 (6-month follow-up), (ii) changes from T0 in measures of the functional impact of pain, (iii) changes from T0 in anxiety-depression scores and (iv) changes from T0 in quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- were to have participated in the past year in the self-hypnosis training program and to agree to take part in these research interviews.
- be 18 years of age or older;
- have received one of the above diagnoses, confirmed by medical record review or physician confirmation;
- report pain that has been present for at least 3 months;
- have a pain intensity over the last 24 hours (24h pain) of at least 4 on a Numerical Rating Scale (NRS) from 0 to 10 at baseline;
You likely can't join if
- have deafness and/or severe cognitive impairment that may impair communication;
- have current or recent psychiatric instability (e.g., active suicidal ideation, active delusional or psychotic thoughts) that could interfere with...
See the full eligibility criteria
- were to have participated in the past year in the self-hypnosis training program and to agree to take part in these research interviews.
- be 18 years of age or older;
- have received one of the above diagnoses, confirmed by medical record review or physician confirmation;
- report pain that has been present for at least 3 months;
- have a pain intensity over the last 24 hours (24h pain) of at least 4 on a Numerical Rating Scale (NRS) from 0 to 10 at baseline;
- be able to read, speak and understand French;
- have Internet access and be able to participate in a telepractice intervention group and complete online questionnaires.
- have deafness and/or severe cognitive impairment that may impair communication;
- have current or recent psychiatric instability (e.g., active suicidal ideation, active delusional or psychotic thoughts) that could interfere with participation, as assessed by a clinical psychologist.
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.